Vascular smooth muscle relaxation by alpha-adrenoceptor blocking action of dobutamine in isolated rabbit aorta

被引:8
作者
Aikawa, J
Fukazawa, M
Ishikawa, M
Moroi, M
Namiki, A
Yamaguchi, T
机构
[1] Third Dept. of Internal Medicine, Ohashi Hospital, Toho University School of Medicine, Tokyo
[2] Third Dept. of Internal Medicine, Ohashi Hospital, Toho University School of Medicine, Meguro-ku, Tokyo, 153
关键词
dobutamine; vascular smooth muscle relaxation; alpha-adrenoceptor blocking action; isolated rabbit thoracic aorta; cyclic AMP;
D O I
10.1097/00005344-199601000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the mechanism of vascular relaxation produced by dobutamine, a positive inotropic agent with beta(1)-adrenergic action. Dobutamine concentration-dependently (10 nM-10 mu M) relaxed ring segments of rabbit aorta partially precontracted with 1 mu M phenylephrine (PE) but did not relax those precontracted with 40 mM K+ or 5 mu M prostaglandin F-2 alpha (PGF(2 alpha)). The relaxation was not completely inhibited by pretreatment with 10 mu M propranolol. Dobutamine did not significantly increase tissue cyclic AMP levels concomitantly with relaxation as does isoproterenol (ISO) in rabbit aorta, Dobutamine produced a parallel rightward shift in concentration-response curves to PE. The Schild plot analysis resulted in a linear regression of a slope of 1.077 +/- 0.077, which was not significantly different from unity. The pA(2) value of dobutamine as compared with PE in rabbit aorta was 6.81 +/- 0.03. Dobutamine causes arterial dilatation mediated not only through a beta-adrenergic action but also through an alpha-adrenergic blocking action in rabbit aorta.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 13 条
[1]   VASCULAR SMOOTH-MUSCLE RELAXATION BY ALPHA-1-ADRENOCEPTOR BLOCKING ACTION OF DENOPAMINE IN ISOLATED RABBIT AORTA [J].
AIKAWA, J ;
KOIKE, K ;
TAKAYANAGI, I .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (03) :440-444
[2]  
AIKAWA J, 1990, J JPN COLL ANGIOL, V30, P1137
[3]   HEMODYNAMIC EFFECT OF DOBUTAMINE IN PATIENTS WITH SEVERE HEART-FAILURE [J].
AKHTAR, N ;
MIKULIC, E ;
COHN, JN ;
CHAUDHRY, MH .
AMERICAN JOURNAL OF CARDIOLOGY, 1975, 36 (02) :202-205
[4]  
ARIENS EJ, 1963, 1 P INT PHARM M, V7, P247
[5]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[6]  
Kanmura Yuichi, 1995, Japanese Journal of Anesthesiology, V44, P2
[7]   CARDIOVASCULAR EFFECTS OF CONTINUOUS INFUSION OF DOBUTAMINE IN PATIENTS WITH SEVERE CARDIAC-FAILURE [J].
LEIER, CV ;
WEBEL, J ;
BUSH, CA .
CIRCULATION, 1977, 56 (03) :468-472
[8]   RELATIONSHIP BETWEEN PLASMA DOBUTAMINE CONCENTRATIONS AND CARDIOVASCULAR-RESPONSES IN CARDIAC-FAILURE [J].
LEIER, CV ;
UNVERFERTH, DV ;
KATES, RE .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (02) :238-242
[9]   POSSIBLE MODES OF ACTION OF DOBUTAMINE IN DOG FEMORAL AND PULMONARY-ARTERIES [J].
MORISHITA, H ;
FURUKAWA, T .
CARDIOVASCULAR RESEARCH, 1980, 14 (02) :103-107
[10]   EFFECTS OF DOBUTAMINE ON ISOLATED CANINE CEREBRAL, CORONARY, MESENTERIC, AND RENAL-ARTERIES [J].
OZAKI, N ;
KAWAKITA, S ;
TODA, N .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :456-461